Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy
暂无分享,去创建一个
P. Parren | G. Gritti | M. Introna | A. Rambaldi | Ronald P. Taylor | F. Beurskens | J. Golay | E. Breij | Fabio Da Roit | P. Engelberts | R. Taylor | R. Taylor